Avocado/Soybean Unsaponifiables (ASU) and joint structure
What 2 graded rows on avocado/soybean unsaponifiables (asu) agree on for joint structure, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Avocado/Soybean Unsaponifiables (ASU) page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Avocado/Soybean Unsaponifiables (ASU) page, with its PubMed record.
Your question
Avocado/Soybean Unsaponifiables (ASU) and joint structure
2 rows · 453 peopleSplit. 1 row found no difference and 1 had mixed results.
- CGrade C× 1
- DGrade D× 1
- Rows
- 2
- Trials
- 2
- People
- 453
What the rows share
From the rowsThe best-graded row, grade C, is a randomized trial of 345 people (2014) and reported mixed results.
The rows run from 108 to 345 people, published from 2002 to 2014: 2 single studies.
The rows
1 no difference · 1 mixed- DGrade DJoint-space narrowing in hip osteoarthritis over 2 years · No difference
Pilot RCT · n 108 · 2002 · Adults with hip osteoarthritis (163 randomised, 108 radiologically evaluable)
Not stated in the abstract · 2 years
No overall difference in joint-space loss (intergroup p = 0.9) and no difference in clinical outcomes. A post-hoc analysis found less narrowing with ASU in the half of patients with the narrowest joints.
Row on the Avocado/Soybean Unsaponifiables (ASU) page · PubMed 11932878 (opens PubMed)
- CGrade CJoint-space narrowing in hip osteoarthritis over 3 years · Mixed
RCT · n 345 · 2014 · Adults with symptomatic hip osteoarthritis (399 randomised, 345 analysed)
300 mg/day · 3 years
Mean joint-space loss did not differ (−0.638 vs −0.672 mm, p = 0.72), but fewer patients progressed by ≥ 0.5 mm (40% vs 50%, p = 0.040). Clinical outcomes did not differ.
Row on the Avocado/Soybean Unsaponifiables (ASU) page · PubMed 23345601 (opens PubMed)